top of page

Michael Siem
资深顾问

资格
美国专利代理人
美国纽约州律师
学历
美国 Illinois Institute of Technology, Chemical Engineering 学士
美国 University of Michigan Law School 法学博士
背景简介
.Specializes in intellectual property litigation, with a focus on patent cases.
.Has appeared before various U.S. federal district courts.
.Litigation experience spans multiple technological fields, including: Pharmaceuticals, Consumer electronics, Chemical processes, Computer networks, Biotechnology.
.Has particular expertise in pharmaceutical litigation under the Hatch-Waxman Act.
.Represents both patentees and accused infringers.
.Handles all stages of litigation, from pre-suit investigations through to trial.
.Handled various pro bono matters.
-
代表案例
.Novartis AG, Novartis Pharmaceuticals Corp., Mitsubishi Tanabe Pharma Corp., and Mitsui Sugar Co. Ltd. v. HEC Pharm Co., Ltd., HEC Pharm Group, and HEC Pharm USA Inc., Civil Action No. 1:15-cv-00151-LPS (D Del.). Mr. Siem is lead counsel for defendants in a Hatch-Waxman action over an ANDA filing concerning fingolimod used in the treatment of patients with relapsing forms of multiple sclerosis.
.Cephalon, Inc., v. Nang Kuang Pharmaceutical Co., Ltd. and CANDA NK-1, LLC, Civil Action No. 1:14-cv-5180 SJ-RER (EDNY). Mr. Siem is lead counsel for defendants in a Hatch-Waxman action over an ANDA filing concerning bendamustine hydrochloride used in the treatment of patients with chronic lymphocytic leukemia
.Eli Lilly and Company and The Trustees of Princeton University, v. Nang Kuang Pharmaceutical Co., Ltd. and CANDA NK-2, LLC,Civil Action No. 1:14-cv-1647-TWP-DKL (SD Ind.). Mr. Siem is counsel for defendants in a Hatch-Waxman action over an ANDA filing concerning pemetrexed used in the treatment of patients with advanced nonsquamous non-small cell lung cancer and malignant pleural mesothelioma.
.D.J. Miller Music Distributors, Inc. v. Strauser et al.; Civil Action No. 0900897 (Middle District of Florida). Mr. Siem was lead counsel on behalf of D.J. Miller Music Distributors, Inc. in a trademark litigation under the Anticybersquatting Consumer Protection Act related to the use and registration of the domain name www.prosing.com. The case ended in a favorable settlement.
bottom of page